dihydroergotamine has been researched along with Acute Pain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banga, AK; Eangoor, P; Joyce, JC; Knaack, JS; Nguyen, HX; Prausnitz, MR; Tas, C | 1 |
Argüelles, CF; Godínez-Chaparro, B; Granados-Soto, V; López-Santillán, FJ; Villalón, CM | 1 |
2 other study(ies) available for dihydroergotamine and Acute Pain
Article | Year |
---|---|
Dihydroergotamine mesylate-loaded dissolving microneedle patch made of polyvinylpyrrolidone for management of acute migraine therapy.
Topics: Acute Pain; Analgesics, Non-Narcotic; Animals; Biological Availability; Dihydroergotamine; Drug Delivery Systems; Drug Liberation; Injections, Subcutaneous; Male; Microinjections; Migraine Disorders; Needles; Povidone; Rats, Hairless; Rats, Sprague-Dawley; Skin; Solubility; Swine | 2017 |
Role of 5-HT₁B/₁D receptors in the reduction of formalin-induced nociception and secondary allodynia/hyperalgesia produced by antimigraine drugs in rats.
Topics: Acute Pain; Animals; Biphenyl Compounds; Chronic Pain; Dihydroergotamine; Disease Models, Animal; Drug Therapy, Combination; Female; Formaldehyde; Hyperalgesia; Methysergide; Nociceptive Pain; Piperazines; Piperidones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin Antagonists; Spiro Compounds; Sumatriptan | 2013 |